EP2436453A1 — Atomiser comprising a counter and an end of operation lock
Assigned to Boehringer Ingelheim International GmbH · Expires 2012-04-04 · 14y expired
What this patent protects
An atomiser for a fluid, in particular for medical aerosol therapy, is proposed. In order to allow simplified operation and improved safety in use, the atomiser has a counter device for counting the operations of the atomiser and the number of containers inserted, wherein the ato…
USPTO Abstract
An atomiser for a fluid, in particular for medical aerosol therapy, is proposed. In order to allow simplified operation and improved safety in use, the atomiser has a counter device for counting the operations of the atomiser and the number of containers inserted, wherein the atomiser is locked against removal of the current container and insertion of a new container, if a certain number of containers inserted has been reached or exceeded.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.